Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • Type: Posters
    • Track: Health Services Research/Health Economics
    • Presentations: 60
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P09.13 - Bone Metastases and Overall Survival in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Pembrolizumab

      00:00 - 00:00  |  Presenter: Parthib Das

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC

    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • Presentations: 17
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P21.02 - Incidence and Outcomes of Brain Metastases in Unresectable Stage III Patients with NSCLC Treated with Durvalumab after Chemoradiation

      00:00 - 00:00  |  Presenter: Sandip H Patel

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P48 - Small Cell Lung Cancer/NET - Chemo - IO

    • Type: Posters
    • Track: Small Cell Lung Cancer/NET
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P48.19 - Outcomes of Patients Treated with First Line Immunotherapy Plus Chemotherapy for ES-SCLC: Real World Outcomes from a Tertiary Academic Center

      00:00 - 00:00  |  Presenter: Sandip H Patel

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 22
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P75.12 - Prognostic Value of Neutrophil to Lymphocyte Ratio in NSCLC Patients Receiving First Line Immune Checkpoint Inhibitor Therapy

      00:00 - 00:00  |  Presenter: Nitya Surya

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P78 - Immunotherapy (Phase II/III Trials) - Immune Checkpoint Inhibitor Single Agent

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 16
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P78.05 - Patterns of irAE During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome

      00:00 - 00:00  |  Presenter: Cameron Champion Wood

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P79 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 9
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P79.04 - A Phase 2 Trial of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis.

      00:00 - 00:00  |  Presenter: Dwight H Owen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.